O6-methylguanine-DNA methyltransferase methylation andTP53 mutation in malignant astrocytomas and their relationships with clinical course
Open Access
- 30 November 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 113 (4), 581-587
- https://doi.org/10.1002/ijc.20625
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Influence of p53 mutations on prognosis of patients with glioblastomaCancer, 2002
- Concurrent Inactivation of RB1 and TP53 Pathways in Anaplastic OligodendrogliomasJournal of Neuropathology and Experimental Neurology, 2001
- Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomasActa Neuropathologica, 2001
- Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating AgentsNew England Journal of Medicine, 2000
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- Genetics of Glioma Progression and the Definition of Primary and Secondary GlioblastomaBrain Pathology, 1997
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- Structure, Function, and Inhibition of O6-Alkylguanine-DNA AlkyltransferaseProgress in Nucleic Acid Research and Molecular Biology, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras geneCancer, 1992